Bluepharma, leader of the CiNTech consortium - Technological Pole for Innovation, Translation and Industrialization of Complex Injectable Medicines - signed, on the 17th of September, the term of acceptance of the Mobilizing Agendas and Green Agendas for Business Innovation within the scope of the Recovery and Resilience.

CiNTech intends to promote the creation and training of the first Technological Pole entirely dedicated to complex injectable medicines in Portugal, in a global investment of 30 million euros corresponding to an incentive of around 21 million euros.

The consortium includes, in addition to Bluepharma, the University of Coimbra, the Iberian Institute of Nanotechnology (INL), and three SMEs (Biotrend, JPM and Joinsteel).

Last News

  • Published: 7 Jun - Read More

  • Published: 7 Jun - Read More

  • It's already the 15th. Peniche and Figueira da Foz host sessions to publicize the potential for internationalization and FDI attraction of the Economy of the Sea

    Published: 7 Jun - Read More

  • From the 10th to the 14th and from the 17th to the 21st of July. Holiday workshops on entrepreneurship for young people aged 8 to 14

    Published: 7 Jun - Read More

  • Empreende XXI finances the implementation of new businesses

    Published: 7 Jun - Read More

Areas

Categories